As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

This lack of testing amplifies the misdiagnosis of RSV, as its symptoms are so similar to other, more common respiratory viruses like flu. A lack of recognition can also be seen in older adults ...

Researchers performed a retrospective case-control study using data from a large US healthcare network to evaluate the effectiveness of the RSVpreF vaccine in protecting older adults against RSV ...

Immune responses to respiratory syncytial virus (RSV) vaccines tended to fall short in older people with weakened immunity, a ...

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...

U.S. approved the RSVpreF vaccine for adults 60 years and older in 2023, recommending it only based on individual’s decisions ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

Cases of RSV across the country are considered "very high," as rates of other acute respiratory illnesses are also high, the ...

In the Lehigh Valley, cases of the flu and RSV are particularly prevalent compared with many other parts of the state.

Since 2023, vaccines are now available and are highly recommended, especially for older adults. Respiratory syncytial virus (RSV) is a common virus that causes mild to severe respiratory infections.

The FDA is adding a warning about Guillain-Barré syndrome to the respiratory syncytial virus vaccines manufactured by GSK and ...

Bon Secours and Prisma Health are implementing new visitor restrictions as cases of influenza and respiratory illnesses rise ...